Rituximab , Cetuximab , Bevacizumab , Alemtuzumab , Trastuzumab Flashcards
Name the Monoclonal Antibodies used in treatment of Cancer
Rituximab
(“coronation ritual”)
Cetuximab
(“tusks”)
Bevacizumab
(“Beverage lady”)
Alemtuzumab
(“Alms”)
Trastuzumab
(“Tapestry weaver”)
Rituximab MOA
Rituximab and Cetuximab are chimeric monoclonal antibodies
(“Chimera sigil”)
binds CD20 on B-cells
(“Grabbing “XX” straps”)
rituximab depletes B cells (binds CD20)
(“Pulling down antibody archer”)
Rituximab can be used to treat …
treats chronic lymphocytic leukemia (CLL)
(“Chronic tapestry with antibody archers and T knights”)
- rituximab treats rheumatoid arthritis
- disease modifying anti-rheumatic drug – DMARD
(“Rheumatic lantern”)
-is useful for immunosuppressive therapy
(e.g. microscopic polyangiitis, Wegener’s granulomatosis)
(“Torn antibody”)
Rituximab Side Effects
can cause immunosuppression and increased risk of infection
(“Immunosuppressed cane”)
-may be associated with a higher risk of progressive multifocal leukoencephalopathy (PML)
(“White laurel leaves”)
-can cause an infusion reaction (e.g. headache, fever, skin rash, pruritus, dyspnea, hypotension)
(“Swollen cherub with ivy”)
-chimeric antibodies (e.g. rituximab, rarely cetuximab) can cause serum sickness e.g. fever, rash, arthralgia within 7-10 days
(“Delayed onset poisoning”)
Cetuximab MOA
(“Tusks”)
binds the epidermal growth factor receptor (EGFR)
- EGFR is a receptor tyrosine kinase
(“Tire swing”)
(“Giraffe”)
Cetuximab can treat …
treats solid tumors
- e.g. colorectal cancer, squamous cell carcinoma
(“Cracked crab”)
Cetuximab Side Effects
can cause a papulopustular acneiform rash
(“Red spots”)
Bevacizumab MOA
(“Beverage Lady”)
binds VEGF
- inhibits growth of blood vessels in tumors binds VEGF
(“Chopping vessels”)
(“Chopped vegetables”)
Bevacizumab can treat …
treats metastatic tumors
- e.g. colorectal cancer, squamous cell carcinoma
(“Cracked crab”)
-treats wet macular degeneration
(“Wet center of retina pillow”)
Bevacizumab Side Effects
-can cause bleeding
(“Blood spatter”)
-increases the risk for thrombotic events
(“Ice clots”)
Alemtuzumab MOA
(“Alms”)
-binds CD52 on B and Tcells
depletes B and T cells (binds CD52)
(“Pulling down antibody archer and T knight”)
(“52 pattern”)
Alemtuzumab can treat…
treats chronic lymphocytic leukemia (CLL)
(“Chronic tapestry with antibody archers and T knights”)
Trastuzumab MOA
(“Tapestry weaver”)
binds epidermal growth factor receptor 2
- HER2, c-erbB2
- HER2 is a receptor tyrosine kinase
(“Tire swing”)
(“Her 2 babies”)
Trastuzumab can treat …
treats HER2 positive breast cancer
(“Crab bra”)
Trastuzumab can cause …
trastuzumab can cause cardiotoxicity
- e.g. decreased LVEF, heart failure
(“Unraveling heart”)